Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: Should we worry?

Magdalena Meszaros1,2, Lucy Meunier1, David Morquin3

  • 1Department of Hepatology, Gastroenterology and Liver Transplantation, Montpellier University Hospital, University of Montpellier, Montpellier, France.

Insights

Abnormal liver function is common in hospitalized COVID-19 patients in Europe, affecting nearly 67%. These liver test abnormalities predict worse disease and increased mortality risk.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Internal Medicine

Background:

  • COVID-19 has been associated with liver injury in studies from China.
  • Limited data exist on liver dysfunction in European COVID-19 patients.

Purpose of the Study:

  • To determine the prevalence of abnormal liver function in hospitalized COVID-19 patients in France.
  • To assess the predictive value of abnormal liver tests for disease severity and mortality.

Main Methods:

  • Retrospective cohort study including 234 RT-PCR confirmed COVID-19 patients.
  • Data collected included clinical, biological, and radiological information.
  • Multivariate logistic regression analysis was used to identify predictors of outcomes.

Main Results:

  • Abnormal liver function was observed in 66.6% of patients upon admission.
  • Abnormal liver tests were associated with in-hospital aggravation (OR=4.1) and mortality (OR=3.3).
  • Statistical significance was found for both associations (P=.004 and P=.04, respectively).

Conclusions:

  • A high prevalence of abnormal liver tests exists in European COVID-19 patients.
  • Abnormal liver function on admission is a significant predictor of severe disease course.
  • Liver dysfunction is linked to increased in-hospital mortality in this population.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
117
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.7K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
289
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
638
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
149
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
4.7K